Second Quarter 2023 Highlights

Dowload report

“Disciplined capital allocation and using our strong financial position wisely to maximize the impact of our highest-conviction companies are crucial to long-term value creation. During the quarter, our dedication to these priorities and our unique ability to seize opportunities in the current market is manifested by our USD 100m investment in Spring Health. Through this investment, Spring Health represents our largest aggregate investment since we commenced our transformation in 2018. We believe Spring Health also has the potential to become one of the most successful investments in Kinnevik’s history.”

Georgi Ganev, CEO of Kinnevik

Key Numbers

Per 30 June 2023

SEK 54.0bn
Net asset value
192
Nav per share
(3)%
Change in nav q/q
(12)%
Change in nav y/y
(9)%
1 year TSR
+3%
5 year TSR

Conference Call 10am CEST

Link to the webcast (listen only):

https://edge.media-server.com/mmc/p/2e7gcgkd

Those who wish to ask questions during the conference call are welcome to register via the below link. Participants will receive dial-in numbers and confirmation code upon registration. Please make sure to register and dial in a few minutes before the call begins.

Link to conference call (for participants):

https://register.vevent.com/register/BIb062ed0e47e1498986afe08040314541

Kinnevik uses cookies

to make the website work in a good way. Cookies are used, among other things, to save your settings, analyze how you surf and adapt content to suit you and certain cookies come from companies we work with. You can change your consent at any time on the Personal data & Cookies page.